Protein S is anticoagulant in the absence of activated protein C because of
direct interactions with coagulation Factors Xa and Va. Synthetic peptides
corresponding to amino acid sequences of protein S were tested for their a
bility to inhibit prothrombinase activity. The peptide containing the C-ter
minal sequence of protein S, residues 621-635 (PSP14), reversibly inhibited
prothrombinase activity in the presence but not in the absence of Factor V
a (K-i similar to 2 mu M). PSP14 inhibition of prothrombinase was independe
nt of phospholipids but could be competitively overcome by increasing Facto
r Xa concentrations, suggesting that the C-terminal region of protein S may
compete for a Factor Xa binding site on Factor Va. Studies using peptides
with amino acid substitutions suggested that lysines 630, 631, and 633 were
critical residues. PSP14 inhibited Factor Va activity in Factor Xa-one-sta
ge clotting assays. PSP14 inhibited protein S binding to immobilized Factor
Va. When preincubated with protein S, antibodies raised against PSP14 inhi
bited binding of protein S to Factor Va and blocked inhibition of prothromb
inase activity by protein S, These results show that the C-terminal region
of protein S containing residues 621-635 is essential for binding of protei
n S to Factor Va and that this interaction contributes to anticoagulant act
ion.